BioCentury
ARTICLE | Regulation

The three legs of FDA's initiatives

February 3, 2003 8:00 AM UTC

Faster, Says McClellan

FDA's initiatives to improve innovation in medical technology focuses on three major areas: Avoiding or reducing the number of cycles required to review a product; improving the quality and efficiency of the review process; and facilitating new product development by drafting new guidance documents for particular diseases and emerging technologies. ...